Clinical trial
Therapeutic Efficacy of Atovaquone-proguanil and Artesunate-atovaquone-proguanil for the Treatment of Uncomplicated P. Falciparum Malaria in Areas of Multidrug Resistance in Cambodia.
NCT02297477 is registered in ClinicalTrials.gov with Armed Forces Research Institute of Medical Sciences, Thailand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Efficacy of Atovaquone-proguanil and Artesunate-atovaquone-proguanil for the Treatment of Uncomplicated P. Falciparum Malaria in Areas of Multidrug Resistance in Cambodia.
- Lead sponsor
- Armed Forces Research Institute of Medical Sciences, Thailand
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2014
- Completion date
- December 31, 2021
- Enrollment
- 205 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.